JACC. Advances
Journal
-
- Overview
-
- Identity
-
- View All
-
Overview
publication venue for
-
Frailty Status Predicts Adverse Outcomes in Ambulatory Heart Failure With Preserved Ejection Fraction..
5:-.
2026
-
Neighborhood Social Vulnerability and Cardiovascular Risk After Allogeneic Hematopoietic Cell Transplantation..
5:-.
2026
-
The Association Between Office, Video, and Telemanagement Encounters and GDMT Optimization in Advanced HFrEF..
5:-.
2025
-
Social Determinants of Cardiovascular Aging..
4:-.
2025
-
Frailty Predicts Geriatric and Cardiovascular Adverse Outcomes After TAVR: A 5-Year Real-World Analysis..
4:-.
2025
-
Goal Attainment Among Older Adults With Ischemic Heart Disease Using Mobile-Health Cardiac Rehabilitation in RESILIENT..
4:-.
2025
-
Noninvasive Cardiac Imaging in Older Adults: Diagnostic Challenges and Prognostic Implications Across Modalities..
4:-.
2025
-
Incorporating Implementation Science Into Frailty Interventions for Cardiovascular Disease..
4:-.
2025
-
Cumulative Burden of Geriatric Conditions and Cardiovascular Outcomes in Older Adults: Analysis From ARIC..
4:-.
2025
-
Postoperative Atrial Fibrillation and Risk of Development of Dementia..
4:-.
2025
-
Older Adults With NSTEMI: Picking the Patient's Future..
4:-.
2025
-
Percutaneous Coronary Intervention or Medical Therapy for Chronic Total Occlusion in Older Adults..
4:-.
2025
-
Toward a Universal Definition of Physical Frailty Syndrome in Older Adults With Cardiovascular Disease..
4:-.
2025
-
Representation of Older Adults in the AHA/ACC/HFSA Guideline for the Management of Heart Failure..
4:-.
2025
-
Patient-Reported Outcomes in Older Adults With Transthyretin Amyloid Cardiomyopathy: When the Heart Isn't the Only Matter..
4:-.
2025
-
Targeted Geriatric Assessment to Predict Outcomes in Older Adults With Heart Failure..
4:-.
2025
-
Sex-Dependent Effects of Body Fat on Cardiac Function and Outcomes in Community-Dwelling Older Adults..
4:-.
2025
-
Frailty, Pitavastatin, and Major Adverse Cardiovascular Events Among People With HIV..
4:-.
2025
-
Sex Differences in Cardiovascular Outcomes of Intravascular Imaging-Guided PCI: A Meta-Analysis of Randomized Controlled Trials..
4:-.
2025
-
Personalizing Temperature Targets After Cardiac Arrest: Our Neurologically Driven Approach..
4:-.
2025
-
Comparing Claims Data to Stroke and Bleeding in the NCDR Left Atrial Appendage Occlusion Registry..
4:-.
2025
-
Establishing Cardiovascular Centers on Aging: The Cleveland Clinic Experience..
4:-.
2025
-
Effect of Frailty on Cardiovascular Clinical Trials: A Systematic Review and Meta-Analysis..
4:-.
2025
-
Reply: Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism..
4:-.
2025
-
The Effect of 12-Week e-Cigarette Use on Smoking Abstinence at 1 Year: The E3 Trial..
4:-.
2025
-
Long-Term Outcomes Following Catheter-Based Therapies in Older Adults With Acute Pulmonary Embolism..
4:-.
2025
-
Cardiac Amyloidosis in Older Adults With a Focus on Frailty: JACC: Advances Expert Consensus..
4:-.
2025
-
Identification of Frailty Clusters Using Cross-Sectional Frailty and Frailty Trajectory: Cohort of Heart Failure Veterans..
4:-.
2025
-
Predicting Thoracic Aortic Dissection in a Diverse Biobank Using a Polygenic Risk Score..
4:-.
2025
-
Healthcare Expenditure on Atrial Fibrillation in the United States: The Medical Expenditure Panel Survey 2016 to 2021..
4:-.
2025
-
Prevent Frailty, Prevent Cardiovascular Disease: Early Identification of Patients at Risk..
4:-.
2025
-
Post-Transcatheter Aortic Valve Replacement Antithrombotic Treatment in Nonindicated Patients: Updated Systematic Review and Network Meta-Analysis..
4:-.
2025
-
Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target Trial Emulation..
4:-.
2025
-
Primary Prevention of Cardiovascular Disease in Asia: Opportunities and Solutions: A Narrative Review..
4:-.
2025
-
Primary Prevention of Cardiovascular Disease in Asia: Challenges: A Narrative Review..
4:-.
2025
-
Geriatric Vulnerabilities Among Adults With Heart Failure With Preserved Ejection Fraction: A Cross-Continent Evaluation..
4:-.
2025
-
Physicians' Perspectives on a Best Practice Alert to Improve Guideline-Directed Medical Therapy in Heart Failure..
4:-.
2025
-
Social Determinants of Health and 30-Day Readmission After Acute Myocardial Infarction in the REGARDS Study..
4:-.
2025
-
Stabilizing Stable Coronary Artery Disease: No Beta-Blocker, No Problem?.
4:-.
2025
-
Sex Differences in the Safety and Efficacy of Different Durations of DAPT After PCI..
4:-.
2025
-
Comparison of Physical Frailty Assessments in Heart Failure With Preserved Ejection Fraction..
3:-.
2024
-
Dietary Interventions in Heart Failure With Preserved Ejection Fraction: A Scoping Review..
4:-.
2024
-
The Relationship Between Quantitative Ischemia, Early Revascularization, and Major Adverse Cardiovascular Events: A Multicenter Study..
4:-.
2024
-
The Impact of Frailty on Patients With AF and HFrEF Undergoing Catheter Ablation: A Nationwide Population Study..
3:-.
2024
-
Impact of Frailty and Delirium Among Older Adults Admitted With Acute Decompensated Heart Failure..
3:-.
2024
-
Left Ventricular Wall Stress and Incident Heart Failure in Elderly Community-Dwelling Individuals..
3:-.
2024
-
Is It Time for Population-Based Screening for Transthyretin Cardiac Amyloidosis?.
3:-.
2024
-
Polypharmacy and Guideline-Directed Medical Therapy Initiation Among Adults Hospitalized With Heart Failure..
3:-.
2024
-
Comprehensive Geriatric Assessment to Optimize the Management of Older Patients With Transthyretin Cardiac Amyloidosis..
3:-.
2024
-
Trend of Controlled Low-Density Lipoprotein Cholesterol in Older Adults With a History of Myocardial Infarction or Stroke..
3:-.
2024
-
Is the Weight Over? An Improved HFpEF Risk Score..
3:-.
2024
-
Prognostic Value of Cardio-Ankle Vascular Index for Cardiovascular and Kidney Outcomes: Systematic Review and Meta-Analysis..
3:-.
2024
-
Association Between Frailty and Management and Outcomes of Acute Myocardial Infarction Complicated by Cardiogenic Shock..
3:-.
2024
-
Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries With Heart Failure..
3:-.
2024
-
JACC.
3.
2024
-
Derivation of an Annualized Claims-Based Major Adverse Cardiovascular Event Estimator in Type 2 Diabetes..
3:-.
2024
-
Hypertensive Disorders of Pregnancy: Innovative Management Strategies..
3:-.
2024
-
Initiation of Statins for Primary Prevention in Heart Failure With Preserved Ejection Fraction..
3:-.
2024
-
Cardiovascular Disease in the Older Adult: Where Are We 4 Decades Later?.
3.
2024
-
Association Between Left Ventricular Scar and Ventricular Ectopy in People Living With and Without HIV..
2.
2023
-
Clinical Applications, Methodology, and Scientific Reporting of Electrocardiogram Deep-Learning Models: A Systematic Review..
2.
2023
-
Identifying Patients With Peripheral Artery Disease Using the Electronic Health Record: A Pragmatic Approach..
2.
2023
-
Life's Essential 8: Optimizing Health in Older Adults..
2.
2023
-
JACC: Advances.
2.
2023
-
Geriatric Condition Burden in Cardiovascular Clinics..
2:-.
2023
-
JACC: Advances.
2.
2023
-
One Thing Leads to Another: Embracing Complexity in Geriatric Cardiology..
2:-.
2023
-
Hierarchical Development of Physical Frailty and Cognitive Impairment and Their Association With Incident Cardiovascular Disease..
2.
2023
-
A Computable Algorithm for Medication Optimization in Heart Failure With Reduced Ejection Fraction..
2:-.
2023
-
The Multidisciplinary Heart Team in Cardiovascular Medicine: Current Role and Future Challenges..
2:-.
2023
-
Geriatric Cardiology: Coming of Age..
1.
2022
-
Apixaban Concentrations in Routine Clinical Care of Older Adults With Nonvalvular Atrial Fibrillation..
1.
2022
-
Histopathology of the Mitral Valve Residual Leaflet in Obstructive Hypertrophic Cardiomyopathy
2023
Identity
International Standard Serial Number (ISSN)